The objective of this study is to estimate the direct medical cost of end-of-life and palliative (EOL/PAL) care for cancer patients during the last six months of their lives — or, during the period from diagnosis to death, if briefer — in 2002 and 2003, in Ontario, Canada. A linkage of cancer registry and administrative data is used to determine the costs of health care resources used during the EOL/PAL care period. Costs are analyzed by cancer diagnosis, location of death, and type of service. The total Ontario Ministry of Health-funded cost of EOL/PAL care for cancer patients is estimated to be about CAD$544 million per year, with an average per patient cost of about $25,000 in 2002–2003. Our results suggest that acute care consumes 75 percent of EOL/PAL funding and that only a small proportion of health care services used by EOL/PAL care cancer patients is likely to be formal palliative care.
Division of Cancer Prevention,National Cancer Institute.Lifestyle and prevention.Bethesda (MD): Author; Online.
5.
Lani ParkS., GoodmanM., ZhangZ.Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort.Int J Cancer2010; 126(2): 490–499.
6.
Canadian Cancer Society.Canadian cancer statistics. Special topics: international variation in cancer incidence, 1993–1997; economic burden of cancer in Canada, 1998.Toronto: CCS; 2004.
7.
Ontario Chronic Disease Prevention Alliance.Economic cost for chronic disease in Canada, 1995–2003.Toronto: Author; Online.
8.
FassbenderK., FainsingerR., BrenneisC.Utilization and costs of the introduction of system-wide palliative care in Alberta, 1993–2000.Palliat Med2005; 19(7): 513–520.
9.
HollanderM.Costs of end-of-life care: findings from the Province of Saskatchewan.Healthc Q2009; 12(3): 50–58.
10.
MarounJ., NgE., BerthelotJ.M.Lifetime costs of colon and rectal cancer management in Canada.Chronic Dis Can2003; 24(4): 91–101.
11.
WillB.P., BerthelotJ.M., Le PetitC.Estimates of the lifetime costs of breast cancer treatment in Canada.Eur J Cancer2000; 36(6): 724–735.
12.
WillB.P., Le PetitC., BerthelotJ.M.Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs.Br J Cancer1999; 79(9-10): 1428–1436.
13.
LongoC.J., DeberR., FitchM.An examination of cancer patients’ monthly “out-of-pocket” costs in Ontario, Canada.Eur J Cancer Care (Engl)2007; 16(6): 500–507.
14.
LongoC.J., FitchM., DeberR.B.Financial and family burden associated with cancer treatment in Ontario, Canada.Support Care Cancer2006; 14(11): 1077–1085.
15.
GuerriereD.N., WongA.Y., CroxfordR.Costs and determinants of privately financed home-based health care in Ontario, Canada.Health Soc Care Community2008; 16(2): 126–136.
16.
EvansW.K.An estimate of the cost effectiveness of gemcitabine in stage IV non-small cell lung cancer.Semin Oncol1996; 23(5 Suppl 10): 82–89.
17.
GroverS.A., CoupalL., ZowallH.The economic burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.CMAJ2000; 162(7): 987–992.
18.
HeroldM., SacchiS., HiekeK.The cost of treating relapsed indolent non-Hodgkin's lymphoma in an international setting: retrospective analysis of resource use.Haematologica2002; 87(7): 719–729, discussion 729.
19.
McLachlanS.A., PintilieM., TannockI.F.Third line chemotherapy in patients with metastatic breast cancer: an evaluation of quality of life and cost.Breast Cancer Res Treat1999; 54(3): 213–223.
20.
LearW., MittmannN., BarnesE.Cost comparisons of managing complex facial basal cell carcinoma: Canadian study.J Cutan Med Surg2008; 12(2): 82–87.
21.
DoyleC., StocklerM., PintilieM.Resource implications of palliative chemotherapy for ovarian cancer.J Clin Oncol1997; 15(3): 1000–1007.
22.
WaiE.S., TrevisanC.H., TaylorS.C.M.Health system costs of metastatic breast cancer.Breast Cancer Res Treat2001; 65(3): 233–240.
23.
LuoW., LaneR., StobartK.The medical care cost of childhood and adolescent cancer in Manitoba, 1990–1995.Chronic Dis Can2002; 23(3): 83–90.
24.
DemeterS.J., JacobsP., ChmielowiecC.The cost of lung cancer in Alberta.Can Respir J2007; 14(2): 81–86.
25.
LeeR.C., ZouD., DemetrickD.J.Costs associated with diffuse large B-cell lymphoma patient treatment in a Canadian integrated cancer care center.Value Health2008; 11(2): 221–230.
26.
O'BrienB.D., BrownM.G., KephartG.Estimation of hospital costs for colorectal cancer care in Nova Scotia.Can J Gas-troenterol2001; 15(1): 43–47.
27.
MenecV.H., NowickiS., BlandfordA.Hospitalizations at the end of life among long-term care residents.Gerontol A Bio Sci Med Sci2009; 64(3): 395–402.
28.
KrahnM.D., ZagorskiB., LaporteA.Healthcare costs associated with prostate cancer: estimates from a population-based study.BJU Int2010; 105(3): 338–346.
29.
JohnsonA.P., AbernathyT., HowellD.Resource utilisation and costs of palliative cancer care in an interdisciplinary health care model.Palliat Med2009; 23(5): 448–459.
30.
BarberaL., PaszatL., ChartierC.Indicators of poor quality end-of-life cancer care in Ontario.J Palliat Care2006; 22(1): 12–17.
31.
BarberaL., SussmanJ., ViolaR.Factors associated with end-of-life health service use in patients dying of cancer.Healthc Policy2010; 5(3): e125–e143.
32.
Canadian Agency for Drugs and Technologies in Health.Guidelines for the economic evaluation of health technologies: Canada.Ottawa: Author; 2006.
33.
ClarkeE.A., MarrettL.D., KreigerN.Cancer registration in Ontario: a computer approach. In: JensonO.M., ParkinD.M., MacLennanR., editors. Cancer registration principles and methods.Lyon (FR): International Agency for Research on Cancer; 1991.
34.
RoblesS.C., MarrettL.D., ClarkeE.A.An application of capture-recapture methods to the estimation of completeness of cancer registration.J Clin Epidemiol1988; 41(5): 495–501.
35.
Ontario Ministry of Health and Long-Term Care.Ontario Health Insurance Plan (OHIP) annual report 2002–2003.Toronto: Author.
36.
Canadian Institute for Health Information.CIHI data quality study of Ontario emergency department visits for fiscal year 2004–2005, executive summary.Ottawa: Author; 2008.
37.
IronK., ZagorskiB.M., SykoraK.Living and dying in Ontario: an opportunity for improved health information. Institute for Clinical Evaluative Sciences (ICES) investigative report.Toronto: ICES; 2008.
HuangJ., BoydC., TyldesleyS.Time spent in hospital in the last six months of life in patients who died of cancer in Ontario.J Clin Oncol2002; 20(6): 1584–1592.
40.
Canadian Institute for Health Information.Average payment per physician report, fee-for-service physicians in Canada, 2004–2005.Ottawa: Author; 2006.
41.
Ontario Ministry of Health and Long-Term Care.Finance and Information Management Branch, Unit costs by type of care, 2002–2003.Toronto: Author; Online. www.mohltcfim.com/cms
42.
Ontario Ministry of Health and Long-Term Care.Ontario Drug Benefit: Trillium Program.Toronto: Author; 2002.
43.
National Cancer Institute.NCI fact sheet: home care for cancer patients.Bethesda (MD): Author; 2009.
44.
Ontario Ministry of Health and Long-Term Care.Seniors’ care: care in your home.Toronto: Author; 2002.
45.
Community Care Access Centre,Ontario Ministry of Health and Long-Term Care. Service maximums for homemaking and personal support services. In: CCAC client services policy manual.Toronto: Author; 2006 Sept.
46.
Ontario's Local Health Integration Networks.The first full year of LHINs in Ontario.Toronto: Author; 2006.
47.
KrzyzanowskaM.K., BarberaL., ElitL.Cancer. In: The POWER study (Project for an Ontario women's health evidence-based report).Toronto: St. Michael's Hospital, Institute for Clinical Evaluative Sciences; 2009. (POWER report; vol.1).
48.
BachP.B., SchragD., BeggC.B.Resurrecting treatment histories of dead patients: a study design that should be laid to rest.JAMA2004; 292(22): 2765–2770.
49.
DumontS., JacobsP., FassbenderK.Costs associated with resource utilization during the palliative phase of care: a Canadian perspective.Palliat Med2009; 23(8): 708–717.
50.
GuerriereD.N., ZagorskiB., FassbenderK.Cost variations in ambulatory and home-based palliative care.Palliat Med2010; 24(5): 523–532.
51.
FassbenderK., FainsingerR.L., CarsonM.Cost trajectories at the end of life: the Canadian experience.J Pain Symptom Manag2009; 38(1): 75–80.
